← Back to Clinical Trials
Recruiting NCT05741918

NCT05741918 Cardiac Output Measurement in Pediatric Intensive Care Unit by Metabolic Monitor (Fick Method) (PEDIA-FICK-ICU)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05741918
Status Recruiting
Phase
Sponsor University Hospital, Montpellier
Condition Intensive Care Units, Pediatric
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2023-08-20
Primary Completion 2025-08

Eligibility & Interventions

Sex All sexes
Min Age 28 Days
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Fick's methodEchocardiography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2023-08-20 with a primary completion date of 2025-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Cardiac output measurement is one of the most frequently used haemodynamic parameter used for intensive care unit (ICU) patients. In pediatric ICU, it is often measured with echocardiography that is a non-invasive method but is operator dependant and can't provide continuous monitoring. The goal of this clinical trial is to evaluate the feasibility of cardiac output measurement by Fick's method, non-invasive and allowing continuous monitoring, in comparison to echocardiography in pediatric intensive care unit.

Eligibility Criteria

Inclusion Criteria: * Patient under 18 years old * Patient over 10 kg * Patient requiring intubation or intubated with a cuffed tube * Patient requiring a central venous line in superior vena cava territory Exclusion Criteria: * Mechanical ventilation with leak * Bad echogenicity preventing echocardiography * Absence of written informed consent * Patient not affiliated to French Health Insurance or not covered by public health insurance * Patient with a legal protection

Contact & Investigator

Central Contact

Arthur GAVOTTO, PH-U

✉ a-gavotto@chu-montpellier.fr

📞 +334.67.33.66.09

Frequently Asked Questions

Who can join the NCT05741918 clinical trial?

This trial is open to participants of all sexes, aged 28 Days or older, up to 17 Years, studying Intensive Care Units, Pediatric. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05741918 currently recruiting?

Yes, NCT05741918 is actively recruiting participants. Contact the research team at a-gavotto@chu-montpellier.fr for enrollment information.

Where is the NCT05741918 trial being conducted?

This trial is being conducted at Montpellier, France.

Who is sponsoring the NCT05741918 clinical trial?

NCT05741918 is sponsored by University Hospital, Montpellier. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology